Ocumension Therapeutics
HKEX:1477

Watchlist Manager
Ocumension Therapeutics Logo
Ocumension Therapeutics
HKEX:1477
Watchlist
Price: 5.19 HKD -8.3% Market Closed
Market Cap: 4.2B HKD
Have any thoughts about
Ocumension Therapeutics?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ocumension Therapeutics

Wall Street analysts forecast Ocumension Therapeutics stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

Lowest
Price Target
8.94 HKD
72% Upside
Average
Price Target
10.12 HKD
95% Upside
Highest
Price Target
12.52 HKD
141% Upside
Ocumension Therapeutics Competitors:
Price Targets
300119
Tianjin Ringpu Bio-Technology Co Ltd
11% Upside
JNJ
Johnson & Johnson
16% Upside
ARVN
Arvinas Inc
150% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
47% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
42% Upside
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
55% Upside
VETO
Vetoquinol SA
27% Upside
688356
Jenkem Technology Co Ltd
82% Upside

Revenue
Forecast

Revenue Estimate
Ocumension Therapeutics

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 3 years is 81%.

500%
Past Growth
81%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Ocumension Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ocumension Therapeutics's stock price target?
Price Target
10.12 HKD

According to Wall Street analysts, the average 1-year price target for Ocumension Therapeutics is 10.12 HKD with a low forecast of 8.94 HKD and a high forecast of 12.52 HKD.

What is Ocumension Therapeutics's Revenue forecast?
Projected CAGR
81%

For the last 4 years the compound annual growth rate for Ocumension Therapeutics's revenue is 500%. The projected CAGR for the next 3 years is 81%.

Back to Top